JPRN-UMIN000005485已完成未知
A CLINICAL STUDY FOR EVALUATING THE SAFETY OF EXCESSIVE CONSUMPTION OF A PLANT STEROL-ENRICHED CHOCOLATE - A CLINICAL STUDY FOR EVALUATING THE SAFETY OF EXCESSIVE CONSUMPTION OF A PLANT STEROL-ENRICHED CHOCOLATE
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- Soiken Inc.
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Subject taking any hypocholesterolemic treatment drugs 2) Subject currently involved in a clinical trial 3) Subject having blood sample of 200 ml or more taken (e.g., donated blood) within 1 month, or 400 ml or more within 3 months of the start of the present study 4) For female subject: pregnancy or possibility of pregnancy, or intention to be pregnant during the study 5) For female subject: breast feeding 6) Subject presenting known allergy or history of hypersensitivity 7) Subject having sitosterolemia 8) Subject receiving treatment for serious liver, renal, cardio-vascular, respiratory, endocrine, of metabolic disorders 9) Subject deemed unsuitable by the investigator
研究者
相似试验
已完成
不适用
A CLINICAL STUDY FOR EVALUATING THE SAFETY OF EXCESS IVE CONSUMPTION OF A PLANT STEROL-ENRICHED YOGHURT DRINKhypercholestemiaJPRN-UMIN000003449Soiken Inc.40
已完成
不适用
A Clinical Study for Evaluating the Safety of Excessive Consumption of Food containing Plant Extract -Open StudyoJPRN-UMIN000032114Oneness support Co., Ltd.15
已完成
不适用
A Clinical Study for Evaluating the Safety of Excessive Consumption of Food containing Pueraria Flower Extract -Open Studyo (Subjects under 30 of BMI)JPRN-UMIN000023476KSO Corporation50
已完成
不适用
A Clinical Study for Evaluating the Safety of Excessive Consumption of Beverages Containing Heat-killed Lactic Acid Bacteria.Healthy adultJPRN-UMIN000016849KSO Corporation44
已完成
不适用
A Clinical Study for Evaluating the Safety of Excessive Consumption of Food Containing Polydextrose A Randomized, Double-blind, Placebo-controlled, Parallel-group Studyo(subjects with fasting serum triglyceride levels 30-199 mg/dL)JPRN-UMIN000016000KSO Corporation30